36 ORAL A Phase I single dose escalation study of the novel Polo-like kinase 1 inhibitor BI 6727 in patients with advanced solid tumours

36 ORAL A Phase I single dose escalation study of the novel Polo-like kinase 1 inhibitor BI 6727 in patients with advanced solid tumours

Saved in:
Bibliographic Details
Published in:European journal of cancer supplements Vol. 6; no. 12; pp. 14 - 15
Main Authors: Schöffski, P, Awada, A, Dumez, H, Gil, T, Bartholomeus, S, Selleslach, J, Taton, M, Fritsch, H, Peter, N, Munzert, G
Format: Journal Article
Language:English
Published: Elsevier Ltd 2008
Subjects:
Hematology, Oncology and Palliative Medicine
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:1359-6349
1878-1217
DOI:10.1016/S1359-6349(08)71968-2